Gilero LLC, later acquired by Sanner GmbH, obtained FDA clearance for a cartridge used with the MS-3 pump for subcutaneous infusion of Remodulin. ICU Medical discontinued the CADD-Legacy system and introduced the CADD-Solis™ pump for intravenous infusion of Remodulin. The company manufactures and distributes Sterile Diluent for Remodulin, a high-pH glycine diluent, to maintain a reliable supply. The Remunity Pump, developed in collaboration with DEKA Research & Development Corp. under an exclusive development and license agreement, is a semi-disposable system for subcutaneous delivery of treprostinil. In November 2019, the company entered into a supply agreement with an affiliate of DEKA to manufacture and supply the Remunity Pump, reimbursing all manufacturing costs. DEKA obtained FDA clearance for a new version of the Remunity Pump, called RemunityPRO, in January 2025, which was launched in September 2025.
Suppliers referenced include DEKA Research & Development Corp., Gilero LLC, ICU Medical, and Sanner GmbH.
United Therapeutics's Comment on Supply Chain
Gilero LLC, later acquired by Sanner GmbH, obtained FDA clearance for a cartridge used with the MS-3 pump for subcutaneous infusion of Remodulin. ICU Medical discontinued the CADD-Legacy system and introduced the CADD-Solis™ pump for intravenous infusion of Remodulin. The company manufactures and distributes Sterile Diluent for Remodulin, a high-pH glycine diluent, to maintain a reliable supply. The Remunity Pump, developed in collaboration with DEKA Research & Development Corp. under an exclusive development and license agreement, is a semi-disposable system for subcutaneous delivery of treprostinil. In November 2019, the company entered into a supply agreement with an affiliate of DEKA to manufacture and supply the Remunity Pump, reimbursing all manufacturing costs. DEKA obtained FDA clearance for a new version of the Remunity Pump, called RemunityPRO, in January 2025, which was launched in September 2025.
Suppliers referenced include DEKA Research & Development Corp., Gilero LLC, ICU Medical, and Sanner GmbH.
Sources:
United Therapeutics Corporation's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on United Therapeutics Corporation’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
